TrialThe Journal of clinical endocrinology and metabolism2009

Saxagliptin added to a thiazolidinedione improves glycemic control in patients with type 2 diabetes and inadequate control on thiazolidinedione alone.

Priscilla Hollander et al.PubMed ↗Publisher ↗

No numbers read from the abstract.